Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rosell, Rafael, Dr, Carcereny, Enric, MD, Gervais, Radj, MD, Vergnenegre, Alain, Prof, Massuti, Bartomeu, MD, Felip, Enriqueta, MD, Palmero, Ramon, MD, Garcia-Gomez, Ramon, MD, Pallares, Cinta, MD, Sanchez, Jose Miguel, MD, Porta, Rut, MD, Cobo, Manuel, MD, Garrido, Pilar, MD, Longo, Flavia, MD, Moran, Teresa, MD, Insa, Amelia, MD, De Marinis, Filippo, MD, Corre, Romain, MD, Bover, Isabel, MD, Illiano, Alfonso, MD, Dansin, Eric, MD, de Castro, Javier, MD, Milella, Michele, MD, Reguart, Noemi, MD, Altavilla, Giuseppe, MD, Jimenez, Ulpiano, MD, Provencio, Mariano, MD, Moreno, Miguel Angel, MD, Terrasa, Josefa, MD, Muñoz-Langa, Jose, MD, Valdivia, Javier, MD, Isla, Dolores, MD, Domine, Manuel, MD, Molinier, Olivier, MD, Mazieres, Julien, Prof, Baize, Nathalie, MD, Garcia-Campelo, Rosario, MD, Robinet, Gilles, MD, Rodriguez-Abreu, Delvys, MD, Lopez-Vivanco, Guillermo, MD, Gebbia, Vittorio, MD, Ferrera-Delgado, Lioba, MD, Bombaron, Pierre, MD, Bernabe, Reyes, MD, Bearz, Alessandra, MD, Artal, Angel, MD, Cortesi, Enrico, MD, Rolfo, Christian, MD, Sanchez-Ronco, Maria, PhD, Drozdowskyj, Ana, PhD, Queralt, Cristina, PhD, de Aguirre, Itziar, PhD, Ramirez, Jose Luis, PhD, Sanchez, Jose Javier, Prof, Molina, Miguel Angel, PhD, Taron, Miquel, PhD, Paz-Ares, Luis, MD
Published in The lancet oncology (01.03.2012)
Published in The lancet oncology (01.03.2012)
Get full text
Journal Article